Prelude Therapeutics Email Format

Biotechnology ResearchDelaware, United States51-200 Employees

Prelude Therapeutics is a biotechnology research company focused on precision oncology. Based in Wilmington, Delaware, it develops medicines aimed at cancer patients with high unmet medical needs. The company pursues targeted protein degradation approaches targeting clinically validated cancer mechanisms, with additional modalities under exploration.

The organization serves researchers, clinicians, and potential pharmaceutical partners seeking novel cancer therapies grounded in precision medicine. Public reporting has described Prelude as a clinical-stage precision oncology company, and in 2026 it presented preclinical data on a development candidate at the AACR meeting, signaling ongoing advancement.

Sign up for free to view info

Company overview Employee directory